Livin and caspase-3 expression are negatively correlated in cervical squamous cell cancer

Objective: Overexpression in cancer cells of inhibitor of apoptosis proteins like livin appears to promote tumorigenesis by regulating expression of proteins involved in apoptosis signaling. Here, the authors investigated expression of livin and an apoptosis protein that is known to inhibit, caspase-3, in cervical squamous cell carcinoma. Materials and Methods: Their expression was assessed for correlation with tumor invasiveness. Immunohistochemistry for livin and caspase-3 was used in 36 normal cervical tissues and in 98 samples of cervical squamous cell carcinoma. The percentage of cells expressing these proteins was compared between normal and cancer samples. Their expression rates in cancer samples were subsequently compared with one another and with the clinical and pathological characteristics of the samples. Results: Livin was more commonly expressed in tumor samples than in normal tissues, while the opposite pattern was observed for caspase-3. Expression of livin was significantly associated with advanced clinical stage, higher pathological grade, and lymph node metastasis (p < 0.05). Expression of caspase-3 was significantly associated with lower clinical stage, lower pathological grade, and lack of lymph node metastasis (p < 0.05). Finally, expression of livin was negatively correlated to caspase-3 expression in cervical squamous cell carcinoma tissue (r = -0.57, p < 0.05). Conclusions: Livin may inhibit apoptosis in cervical squamous cell carcinoma by downregulating caspase-3, thereby promoting disease progression.

Livin; Caspase-3; Cervical squamous cell carcinoma; Immunohistochemtry.

[1] Vesco K.K., Whitlock E.P., Eder M., Burda B.U., Senger C.A., Lutz K.: “Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force”. Ann. Intern. Med., 2011, 155, 698.

[2] Fonseca-Silva T., Farias L.C., Cardoso C.M., Souza L.R., Carvalho Fraga C.A., Oliveira M.V. et al.: “Analysis of p16 (CDKN2A) methylation and HPV-16 infection in oral mucosal dysplasia”. Pathobiology, 2012, 79, 94.

[3] Ernoux-Neufcoeur P., Arafa M., Decaestecker C., Duray A., Remmelink M., Leroy X. et al.: “Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with Stage IV hypopharyngeal carcinoma”. J. Cancer Res. Clin. Oncol., 2011, 137, 173.

[4] Anderson L.A.: “Prophylactic human papillomavirus vaccines: past, present and future”. Pathology, 2012, 44, 1.

[5] Yang D., Song X., Zhang J., Ye L., Wang S., Che X., et al.: “Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells”. Acta Biochim. Biophys. Sin. (Shanghai) 2010, 42, 137.

[6] Liang C.Y., Ma P., Liu X.L.: “RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells”. Zhonghua Yi Xue Za Zhi, 2008, 88, 1703.

[7] Chen L., Ren G.S., Li F., Sun S.Q.: “Expression of livin and vascular endothelial growth factor in different clinical stages of human esophageal carcinoma”. World J. Gastroenterol., 2008, 14, 5749.

[8] Abd-Elrahman I., Hershko K., Neuman T., Nachmias B., Perlman R., Ben-Yehuda D.: “The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity”. Cancer Res., 2009, 69, 5475.

[9] Chougule M.B., Patel A.R., Jackson T., Singh M.: “Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer”. PloS One, 2011, 6, 17733.

[10] Tong J., Xie G., He J., Li J., Pan F., Liang H.: “Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer”. J. Biomed. Biotechnol., 2011, 2011, 740564. Epub 2011, Feb. 20.

[11] Gok M., Rozendaal L., Berkhof J., Visser O., Meijer C.J., van Kemenade F.J.: “Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases”. Br. J. Cancer, 2011, 104, 685.

[12] O’Neal P., Alamdari N., Smith I., Poylin V., Menconi M., Hasselgren P.O.: “Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle”. J. Cell. Biochem., 2009, 108, 963.

[13] Han Y., Gao L., Sun N., Zhang J., Zhang W., Zhou X., et al.: “Effects of Kang-Jia-Wan, a Chinese medicinal herb officinal, on apoptosis induction in goiter of rats”. J. Ethnopharmacol., 2009, 122, 533.

[14] Onori P., DeMorrow S., Gaudio E., Franchitto A., Mancinelli R., Venter J., et al.: “Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis”. Int. J. Cancer, 2009, 125, 565.

[15] Qiu W., Wu B., Wang X., Buchanan M.E., Regueiro M.D., Hartman D.J. et al.: “PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice”. J. Clin. Invest., 2011, 121, 1722.

[16] Chan K.S., Wong C.H., Huang Y.F., Li H.Y.: “Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis”. Cell. Death. Dis., 2010, 1, 57.

[17] Gazzaniga P., Gradilone A., Giuliani L., Gandini O., Silvestri I., Nofroni I., et al.: “Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer”. Ann. Oncol., 2003, 14, 85.

[18] Kumar S., Bryant C.S., Chamala S., Qazi A., Seward S., Pal J., et al.: “Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells”. Mol. Cancer, 2009, 8, 26.

[19] Scarlatti F., Maffei R., Beau I., Codogno P., Ghidoni R.: “Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells”. Cell. Death. Differ., 2008, 15, 1318.

[20] Yang D., Song X., Zhang J., Ye L., Wang S., Che X, et al.: “Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells”. Biosci. Biotechnol. Biochem., 2010, 74, 1039.